Archive signal
Cymbalta
Cymbalta
Summary
Publish an urgent, sourced FAQ and step-by-step patient guide linking to FDA and manufacturer advisories, and push alert distribution to affected audiences immediately.
Meaning
A large-scale pharmaceutical recall (Cymbalta/duloxetine) due to detection of a potentially carcinogenic contaminant is driving consumer-safety and supply-impact attention across healthcare and retail channels.
Trend Saturation Meter
Is this trend still worth making?
Status: Crowded
CrowdedSaturation score 58/100
Getting crowded. Use a sharper angle.
Attention is active, but the window is tightening and competition is rising.
Related signal activity: High
Publishing window: Open
Competition pressure: Moderate
When is the best time to post?
Cymbalta
GOOD WINDOW24h 42m 07s remaining
Good time window remains, but earlier publishing is better.
Estimated from signal freshness and longevity score. Use as a publishing urgency guide, not a guarantee.
Time basis: Eastern Time (ET)
Quick Answer
Why is this signal trending now?
Multiple outlets report an FDA‑linked recall and large bottle counts (300K referenced), producing a concentrated consumer-safety news event and action window for recalls/alternatives.
Why does it matter?
Immediate patient-safety concerns, pharmacy and supply-chain disruptions, regulatory scrutiny, potential legal exposure for manufacturers, and urgent informational needs for affected patients and prescribers.
What content can creators make?
Authoritative explainers on next steps for patients, pharmacy guidance, alternative medications, regulatory updates, timelines for return/replace, and legal/regulatory analysis.
Who should care?
Health journalists, clinical editors, patient-safety teams, and publisher health desks
When is the best time to post?
24h 42m 07s remaining. Good time window remains, but earlier publishing is better. Estimated valid until Jun 20, 2026 16:42 ET.
Signal
Major recall of the antidepressant Cymbalta (duloxetine) due to detection of a potentially cancer-causing contaminant, with large bottle counts and FDA action reported.
Evidence
- A product recall at scale reported by multiple outlets directly affects consumers, supply, pharmacies, and demand — a clear commerce/consumer-safety signal rather than low-context noise.
Evidence Sources
Why Now
Multiple outlets report an FDA‑linked recall and large bottle counts (300K referenced), producing a concentrated consumer-safety news event and action window for recalls/alternatives.
Why It Matters
Immediate patient-safety concerns, pharmacy and supply-chain disruptions, regulatory scrutiny, potential legal exposure for manufacturers, and urgent informational needs for affected patients and prescribers.
AUDIENCE PSYCHOLOGY
Alarm and urgency among patients and caregivers; search behavior focused on 'am I affected?', 'lot numbers', 'alternatives', and 'what to do', while providers seek authoritative guidance.
Possible Next Development
Further lot-specific announcements, expanded recalls, FDA advisory updates, shortage notices, recall logistics and reimbursement guidance, and potential class-action litigation.
Creator Brief
Format & Outlook
Caveat
Details about affected lots, exact contaminant levels, and regulatory determinations may evolve; content must link directly to FDA/manufacturer advisories.
Signal Status
Related Coverage
Frequently Asked Questions
What is this signal?
Major recall of the antidepressant Cymbalta (duloxetine) due to detection of a potentially cancer-causing contaminant, with large bottle counts and FDA action reported.
Why is this signal trending?
Multiple outlets report an FDA‑linked recall and large bottle counts (300K referenced), producing a concentrated consumer-safety news event and action window for recalls/alternatives.
Why does this signal matter?
Immediate patient-safety concerns, pharmacy and supply-chain disruptions, regulatory scrutiny, potential legal exposure for manufacturers, and urgent informational needs for affected patients and prescribers.
What content can creators make from this signal?
Authoritative explainers on next steps for patients, pharmacy guidance, alternative medications, regulatory updates, timelines for return/replace, and legal/regulatory analysis.
When is the best time to post about this signal?
24h 42m 07s remaining. Good time window remains, but earlier publishing is better. Estimated valid until Jun 20, 2026 16:42 ET.
SignalMeaning.com is a trend intelligence tool for creators that helps identify trending topics, publishing urgency, and the best time to post before a signal fades.